Jump to ContentJump to Main Navigation


99,00 € / $149.00*

* Prices subject to change. Shipping costs will be added if applicable.

See all formats and pricing

Institutional Subscription
€ [D] 458.00
RRP for USA, Canada, Mexico
US$ 688.00 *
Individual Subscription
€ [D] 99.00
RRP for USA, Canada, Mexico
US$ 149.00 *
Institutional Subscription
€ [D] 458.00
RRP for USA, Canada, Mexico
US$ 688.00 *
Individual Subscription
€ [D] 458.00
RRP for USA, Canada, Mexico
US$ 688.00 *
Print + Online
Institutional Subscription
€ [D] 550.00
RRP for USA, Canada, Mexico
US$ 825.00 *
Individual Subscription
€ [D] 550.00
RRP for USA, Canada, Mexico
US$ 825.00 *
*Prices subject to change. Shipping costs will be added if applicable.

Heterocyclic Communications

Editor-in-Chief: Strekowski, Lucjan

Editorial Board Member: Murata, Shizuaki / Saczewski, Jaroslaw / Stephens, Chad

6 Issues per year

Increased IMPACT FACTOR 2013: 0.727

Free Trial Access Available!

in order to activate your free access, simply register with De Gruyter Online or log in and go to your personal user account “My De Gruyter”. Please enter your access token PROCESS2014 into the field provided. Once you have redeemed your token, you will be able to access the free content via this journal page. You can find a detailed description of the activation process here. The access is granted for 30 days for all issues published in 2014. Offer valid until September 30, 2014.

  • High quality manuscript processing through ScholarOne Manuscripts®. Submit your research online at http://mc.manuscriptcentral.com/hetcyclcom
  • Rapid publication times
  • Free color figures both in print and online editions
  • Open Access publication option available

Aims and Scope

This bimonthly, peer-reviewed journal publishing preliminary communica-tions, research articles, and reviews on significant developments in all phases of heterocyclic chemistry, including inorganic ring systems, with a particular emphasis on clear presentation of experimental details. The scope of the journal encompasses trends in current research including

  • development of novel synthetic methods
  • rational design and synthesis of new drugs targeting specific biological receptors
  • application of heterocyclic compounds as probes for biomolecules in biophysical and bioanalytical chemistry
  • development of new substrates and catalysts in materials chemistry

Heterocyclic chemistry is a rapidly growing field. By some estimates original research papers in heterocyclic chemistry have increased to more than 60% of organic chemistry literature published. This explosive growth is even greater when considering heterocyclic research published in materials science, physical, biophysical, analytical, bioorganic, pharmaceutical and medicinal journals. There is a need, therefore, for a journal dedicated explicitly to heterocyclic chemistry. For the newest trends and reliable experimen-tal descriptions in this dynamic field turn to Heterocyclic Communications.

Previously published by Freund Publishing House Ltd.


Heterocyclic Communications is covered by the following services:

  • Celdes
  • Chemical Abstracts Service (CAS)
  • Chemical Abstracts Service (CAS) - SciFinder
  • CNKI Scholar (China National Knowledge Infrastructure)
  • EBSCO - Academic Search
  • EBSCO - Chemical Engineering Collection: India
  • EBSCO - TOC Premier
  • EBSCO Discovery Service
  • Elsevier - Reaxys
  • Elsevier - SCOPUS
  • Google Scholar
  • Inspec
  • J-Gate
  • Naviga (Softweco)
  • Primo Central (ExLibris)
  • SCImago (SJR)
  • Summon (Serials Solutions/ProQuest)
  • TDOne (TDNet)
  • Thomson Reuters - Current Contents/Physical, Chemical and Earth Sciences
  • Thomson Reuters - Journal Citation Reports/Science Edition
  • Thomson Reuters - Science Citation Index Expanded
  • Ulrich's Periodicals Directory/ulrichsweb
  • WorldCat (OCLC)

Lucjan Strekowski, Georgia State University, Atlanta, USA (lucjan@gsu.edu)

Associate Editors
Shizuaki Murata, Nagoya University, Nagoya, Japan (murata@urban.env.nagoya-u.ac.jp)
Jaroslaw Saczewski, Medical University of Gdansk, Gdansk, Poland (js@gumed.edu.pl)
Chad E. Stephens, Georgia Regents University, Augusta, USA (cstephe7@gru.edu)

Editorial Board
S. Abu-Orabi, Association of Arab Universities, Amman, Jordan (abuorabi@excite.com)
S. Achilefu, Washington University, St. Louis, USA (achilefus@mir.wustl.edu)
E.B. Arevalo-Garcia, Educational Research Institute, Warsaw, Poland (ebarevalog@gmail.com)
A. Baumstark, Georgia State University, Atlanta, USA (abaumstark@gsu.edu)
M. Brimble, University of Auckland, Auckland, New Zealand (m.brimble@auckland.ac.nz)
R.A. Bunce, Oklahoma State University, Stillwater, USA (rab@okstate.edu)
M. Elliott, University of Cardiff, Cardiff, UK (elliottmc@cardiff.ac.uk)
D.C. Gautam, University of Rajasthan, Jaipur, India (drdcgautam@yahoo.co.in)
M.W. Germann, Georgia State University, Atlanta, USA (mwg@gsu.edu)
D. Hamelberg, Georgia State University, Atlanta, USA (dhamelberg@gsu.edu)
M.M. Henary, Georgia State University, Atlanta, USA (mhenary1@gsu.edu)
H. Kiyota, Okayama University, Okayama, Japan (kiyota@okayama-u.ac.jp)
K. Kiec-Kononowicz, Jagiellonian University, Kraków, Poland (mfkonono@cyf-kr.edu.pl
M. Kumar, University of Rajasthan, Jaipur, India (mahendrakpathak@gmail.com)
H. Nishino, Kumamoto University, Kumamoto, Japan (nishino@sci.kumamoto-u.ac.jp)
T. Okano, Jikei University, Tokyo, Japan (okano@jikei.ac.jp)
S.S. Panda, University of Florida, Gainesville, USA (sspanda12@gmail.com)
S.E. Patterson, UMN Center for Drug Design, Minneapolis, USA (patte219@umn.edu)
J. Reddy, Dr. Jagath Reddy's Heterocyclics, Hyderabad, India (jagathreddy@heterocyclics.com)
S. Routier, University of Orléans, Orléans, France (sylvain.routier@univ-orleans.fr)
A. Rykowski, University of Podlasie, Siedlce, Poland (rykowski@ap.siedlce.pl)
F. Saczewski, Medical University of Gdansk, Gdansk, Poland (saczew@amg.gda.pl)
S.W. Schneller, University of Auburn, Auburn, USA (schnest@auburn.edu)
B.C.G. Söderberg, University of West Virginia, Morgantown, USA (bjorn.soderberg@mail.wvu.edu)
V. Traven, Russian University of Chemical Technology, Moscow, Russia (traven@muctr.edu.ru)
K. Weisz, Ernst Moritz Arndt University, Greifswald, Germany (weisz@uni-greifswald.de)
P.-F. Xu, Lanzhou University, Lanzhou, China (xupf@lzu.edu.cn)
P. Zajdel, Jagiellonian University Medical College, Kraków, Poland (pawel.zajdel@uj.edu.pl)
A. Zawisza, University of Łódź, Łódź, Poland (aniazawisza@poczta.onet.pl)

Please log in or register to comment.
  • I would really appreciate if you can update me about the publishing charges of Research Article in Heterocyclic Communications

    posted by: Rayees Mohammed on 2012-06-27 09:16 AM (Europe/Berlin)

  • Thanks for your interest! There are no publishing charges for this journal.

    posted by: De Gruyter Online on 2012-06-29 02:40 PM (Europe/Berlin)

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.